









市場
/
株式
/
nasdaq-bsx
/

Boston Scientific Corp

BSX

95.785USD

-0.275-0.29%

終値 12/29, 16:00（ET）15分遅れの株価

141.98B時価総額

50.74直近12ヶ月PER



Boston Scientific Corp

95.785

-0.275-0.29%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Boston Scientific Corp 企業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corpの企業情報



企業コードBSX

会社名Boston Scientific Corp

上場日May 19, 1992

最高経営責任者「CEO」Mahoney (Michael F)

従業員数53000

証券種類Ordinary Share

決算期末May 19

本社所在地300 Boston Scientific Way

都市MARLBOROUGH

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号01752-1234

電話番号15086834000

ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html

企業コードBSX

上場日May 19, 1992

最高経営責任者「CEO」Mahoney (Michael F)

Boston Scientific Corpの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

Mr. Edward J. Ludwig

Lead Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

他の

1.38B

27.25%

地域別USD

会社名

収益

比率

United States

3.22B

63.70%

EMEA (Europe, Middle East and Africa)

878.00M

17.35%

Asia Pacific

790.00M

15.61%

Latin America and Canada

169.00M

3.34%

事業別

地域別

事業別USD

会社名

収益

比率

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

他の

1.38B

27.25%

株主

更新時刻: Sat, Nov 8

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

他の

72.63%

株主統計

比率

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

他の

72.63%

種類

株主統計

比率

Investment Advisor

50.78%

Investment Advisor/Hedge Fund

29.09%

Hedge Fund

4.91%

Pension Fund

2.94%

Research Firm

2.73%

Bank and Trust

1.89%

Sovereign Wealth Fund

1.58%

Family Office

0.23%

Private Equity

0.18%

他の

5.66%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

2858

1.40B

94.34%

-402.85K

2025Q3

2905

1.40B

94.56%

+9.92M

2025Q2

2818

1.39B

94.08%

+7.87M

2025Q1

2724

1.38B

93.98%

-8.23M

2024Q4

2559

1.38B

93.68%

+12.79M

2024Q3

2401

1.36B

94.13%

-3.01M

2024Q2

2325

1.37B

94.20%

+2.64M

2024Q1

2212

1.37B

95.15%

-32.63M

2023Q4

2153

1.38B

96.34%

-8.17M

2023Q3

2083

1.39B

95.41%

+17.41M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

136.47M

9.21%

+2.53M

+1.89%

Jun 30, 2025

Fidelity Management & Research Company LLC

99.47M

6.71%

-17.98M

-15.31%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

78.19M

5.28%

+380.40K

+0.49%

Jun 30, 2025

State Street Investment Management (US)

65.19M

4.4%

+713.38K

+1.11%

Jun 30, 2025

PRIMECAP Management Company

34.66M

2.34%

-1.83M

-5.03%

Jun 30, 2025

Geode Capital Management, L.L.C.

32.42M

2.19%

+622.60K

+1.96%

Jun 30, 2025

Capital World Investors

28.52M

1.93%

-33.95K

-0.12%

Jun 30, 2025

Managed Account Advisors LLC

22.05M

1.49%

+765.61K

+3.60%

Jun 30, 2025

The Bollard Group, LLC

20.08M

1.36%

-411.38K

-2.01%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Boston Scientific Corpの上位5名の株主は誰ですか？



Boston Scientific Corpの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は136.47M株を保有しており、これは全体の9.21%に相当します。
Fidelity Management & Research Company LLCは99.47M株を保有しており、これは全体の6.71%に相当します。
BlackRock Institutional Trust Company, N.A.は78.19M株を保有しており、これは全体の5.28%に相当します。
State Street Investment Management (US)は65.19M株を保有しており、これは全体の4.40%に相当します。
PRIMECAP Management Companyは34.66M株を保有しており、これは全体の2.34%に相当します。